首页> 外国专利> Detection method of relative morbidity risk of atopic dermatitis by gene single nucleotide polymorphism analysis

Detection method of relative morbidity risk of atopic dermatitis by gene single nucleotide polymorphism analysis

机译:基因单核苷酸多态性分析检测特应性皮炎相对发病风险的方法

摘要

The present invention relates to individual polymorphisms derived by analyzing gene polymorphisms of two or more atopic dermatitis development-related genes in a sample isolated from a statistically significant number of individuals. Obtain a relative ratio (percentage%), calculate the odds ratio for a specific genetic polymorphism from the relative ratio, and the odds ratio is synergistically higher than the odds ratio for an individual genetic polymorphism. A method for determining a relative morbidity risk of atopic dermatitis in a subject using a combination of the gene polymorphisms as a criterion. From the analysis of the major factors involved in the development and progression of AD and the interaction between these genes, prediction of drug sensitivity of AD patients based on those genes and selection of AD preventive and / or therapeutic drugs that eliminate adverse drug reactions, Alternatively, the method is useful for determining a diagnosis method and a treatment method for AD, which is characterized by using the method for detecting the risk of morbidity.
机译:本发明涉及通过分析从统计学上显着数量的个体分离的样品中两个或更多个特应性皮炎发展相关基因的基因多态性而衍生的个体多态性。获得相对比率(百分比%),从相对比率中计算特定遗传多态性的优势比,优势比协同地高于单个遗传多态性的优势比。一种使用基因多态性的组合作为标准确定受试者中特应性皮炎的相对发病风险的方法。通过分析涉及AD发生和发展的主要因素以及这些基因之间的相互作用,根据这些基因预测AD患者的药物敏感性,并选择可消除不良药物反应的AD预防和/或治疗药物,或者该方法对于确定AD的诊断方法和治疗方法是有用的,其特征在于使用用于检测发病风险的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号